Experimental lobar pneumonia due to penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in immunocompetent and neutropenic rats: efficacy of penicillin and teicoplanin treatment

被引:11
作者
Candiani, G
Abbondi, M
Borgonovi, M
Williams, R
机构
[1] Lepetit Research Center, Hoechst Marion Roussel, 21040 Gerenzano (Varese)
关键词
D O I
10.1093/jac/39.2.199
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Lobar pneumonia models were established in rats by intratracheal inoculation of either penicillin-susceptible (immunocompetent model) or penicillin-resistant (immunocompetent and neutropenic models) Streptococcus pneumoniae, Untreated animals maintained a relatively high bacterial load in the lungs but only occasionally developed bacteraemia or pleurisy, The infection was rarely fatal in immunocompetent rats, but immunocompromised rats frequently died, Treatment im with 10,000 IU/kg of procaine penicillin G (12 h after infection then bid for 3 days) or with a single iv dose of 5 or 10 mg/kg of teicoplanin significantly reduced lung bacterial loads of rats infected with the penicillin-susceptible strain. Against the penicillin-resistant strain, teicoplanin displayed a significant activity regardless of the immununological status of the animals, Penicillin G significantly reduced lung bacterial load of the penicillin-resistant strain only in immunocompetent rats and at a higher dose than needed in treatment of the penicillin-susceptible infection. The experimental models described here could be suitable for studying the efficacy of antibacterial agents against pulmonary infections caused by penicillin-susceptible and penicillin-resistant S. pneomoniae strains.
引用
收藏
页码:199 / 207
页数:9
相关论文
共 18 条
[1]  
[Anonymous], M7A2 NCCLS
[2]   INVIVO EFFICACY OF A NEW FLUOROQUINOLONE, SPARFLOXACIN, AGAINST PENICILLIN-SUSCEPTIBLE AND PENICILLIN-RESISTANT AND MULTIRESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE IN A MOUSE MODEL OF PNEUMONIA [J].
AZOULAYDUPUIS, E ;
VALLEE, E ;
VEBER, B ;
BEDOS, JP ;
BAUCHET, J ;
POCIDALO, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2698-2703
[3]   ANTIPNEUMOCOCCAL ACTIVITY OF CIPROFLOXACIN, OFLOXACIN, AND TEMAFLOXACIN IN AN EXPERIMENTAL MOUSE PNEUMONIA MODEL AT VARIOUS STAGES OF THE DISEASE [J].
AZOULAYDUPUIS, E ;
BEDOS, JP ;
VALLEE, E ;
HARDY, DJ ;
SWANSON, RN ;
POCIDALO, JJ .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :319-324
[4]   EFFICACY OF CONTINUOUS VERSUS INTERMITTENT ADMINISTRATION OF PENICILLIN-G IN STREPTOCOCCUS-PNEUMONIAE PNEUMONIA IN NORMAL AND IMMUNODEFICIENT RATS [J].
BAKKERWOUDENBERG, IAJM ;
VANDENBERG, JC ;
FONTIJNE, P ;
MICHEL, MF .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (02) :131-135
[5]   PHARMACOKINETICS OF [C-14] TEICOPLANIN IN MALE-RATS AFTER SINGLE INTRAVENOUS DOSE [J].
BERNAREGGI, A ;
CAVENAGHI, L ;
ASSANDRI, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) :733-738
[6]   STRONG ASSOCIATION BETWEEN CAPSULAR TYPE AND VIRULENCE FOR MICE AMONG HUMAN ISOLATES OF STREPTOCOCCUS-PNEUMONIAE [J].
BRILES, DE ;
CRAIN, MJ ;
GRAY, BM ;
FORMAN, C ;
YOTHER, J .
INFECTION AND IMMUNITY, 1992, 60 (01) :111-116
[7]  
*BRIT PHARM, 1980, BRIT PHARM, pA122
[8]   EFFECTS OF DOSAGE, PEAK AND TROUGH CONCENTRATIONS IN SERUM, PROTEIN-BINDING, AND BACTERICIDAL RATE ON EFFICACY OF TEICOPLANIN IN A RABBIT MODEL OF ENDOCARDITIS [J].
CHAMBERS, HF ;
KENNEDY, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (04) :510-514
[9]  
Institute S.A.S., 1990, SAS STAT US GUID VER, P891
[10]   IN-VIVO EFFICACY OF A BROAD-SPECTRUM CEPHALOSPORIN, CEFTRIAXONE, AGAINST PENICILLIN-SUSCEPTIBLE AND PENICILLIN-RESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE IN A MOUSE PNEUMONIA MODEL [J].
MOINE, P ;
VALLEE, E ;
AZOULAYDUPUIS, E ;
BOURGET, P ;
BEDOS, JP ;
BAUCHET, J ;
POCIDALO, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) :1953-1958